Dimensional Fund Advisors LP Protagonist Therapeutics, Inc Transaction History

Dimensional Fund Advisors LP

$449 Billion
Q3 2025

A detailed history of Dimensional Fund Advisors LP transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 438,515 shares of PTGX stock, worth $37.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

438,515

Previous 180,050 143.55%

Holding current value

$37.1 Million

Previous $9.95 Million 192.73%

% of portfolio

0.01%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	$49.7 - $67.42 $12.8 Million - $17.4 Million	258,465 Added 143.55%	438,515 $29.1 Million
Q2 2025 Aug 12, 2025	BUY	$40.89 - $56.37 $2.39 Million - $3.3 Million	58,496 Added 48.12%	180,050 $9.95 Million
Q1 2025 May 13, 2025	SELL	$35.09 - $59.76 $3.65 Million - $6.22 Million	-104,046 Reduced 46.12%	121,554 $5.88 Million
Q4 2024 Feb 13, 2025	BUY	$38.51 - $48.43 $423 - $532	11 Added 0.0%	225,600 $8.71 Million
Q3 2024 Nov 07, 2024	SELL	$33.72 - $47.33 $13.2 Million - $18.5 Million	-390,583 Reduced 63.39%	225,589 $10.1 Million

Q2 2024 Aug 09, 2024	SELL	$24.66 - $34.8 $4.32 Million - $6.1 Million	-175,172 Reduced 22.14%	616,172 $21.4 Million
Q1 2024 May 10, 2024	SELL	$21.79 - $32.15 $548,955 - $809,954	-25,193 Reduced 3.09%	791,344 $22.9 Million
Q4 2023 Feb 07, 2024	SELL	$14.05 - $23.44 $1.75 Million - $2.92 Million	-124,737 Reduced 13.25%	816,537 $18.7 Million
Q3 2023 Nov 09, 2023	SELL	$16.68 - $23.66 $1.63 Million - $2.31 Million	-97,831 Reduced 9.41%	941,274 $15.7 Million
Q2 2023 Aug 09, 2023	SELL	$18.02 - $29.36 $4.02 Million - $6.55 Million	-223,154 Reduced 17.68%	1,039,105 $28.7 Million
Q1 2023 May 12, 2023	BUY	$10.78 - $25.38 $1.99 Million - $4.7 Million	185,033 Added 17.18%	1,262,259 $29 Million
Q4 2022 Feb 09, 2023	BUY	$7.36 - $11.17 $1.89 Million - $2.87 Million	256,788 Added 31.3%	1,077,226 $11.8 Million
Q3 2022 Nov 10, 2022	SELL	$7.86 - $11.71 $254,168 - $378,666	-32,337 Reduced 3.79%	820,438 $6.92 Million
Q2 2022 Aug 12, 2022	SELL	$7.06 - $25.52 $71,426 - $258,185	-10,117 Reduced 1.17%	852,775 $6.75 Million
Q1 2022 May 13, 2022	SELL	$23.34 - $36.08 $274,455 - $424,264	-11,759 Reduced 1.34%	862,892 $20.4 Million
Q4 2021 Feb 09, 2022	SELL	$17.63 - $37.1 $19,058 - $40,105	-1,081 Reduced 0.12%	874,651 $29.9 Million
Q3 2021 Nov 12, 2021	BUY	$12.95 - $49.69 $1.1 Million - $4.21 Million	84,716 Added 10.71%	875,732 $15.5 Million
Q2 2021 Aug 12, 2021	BUY	$25.57 - $44.88 $3.45 Million - $6.05 Million	134,915 Added 20.56%	791,016 $35.5 Million
Q1 2021 May 14, 2021	BUY	$19.02 - $31.15 $124,790 - $204,375	6,561 Added 1.01%	656,101 $17 Million
Q4 2020 Feb 25, 2021	BUY	$18.49 - $25.13 $12 Million - $16.3 Million	649,540 New	649,540 $13.1 Million

Others Institutions Holding PTGX

# of Institutions

296

Shares Held

66.9M

Call Options Held

139K

Put Options Held

40.7K

View Full List

About Protagonist Therapeutics, Inc

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $4.15B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

More about PTGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Protagonist Therapeutics, Inc Transaction History